文献速递角膜与眼表疾病

聚-ε-赖氨酸接触镜作为药物治疗真菌性角膜炎的递送装置开发

Development of a Poly-ε-Lysine Contact Lens as a Drug Delivery Device for the Treatment of Fungal Keratitis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

本研究将两性霉素B(AmpB,0至30 μg/mL)与聚-ε-赖氨酸(pεK)水凝胶结合,开发用于真菌性角膜炎的药物递送接触镜。AmpB pεK凝胶在18小时对白色念珠菌显示杀真菌活性,药物释放高于治疗水平(0.188 μg/mL)达72小时,对HCE-T角膜上皮细胞系无细胞毒性,结论提示其有潜力作为体内抗真菌绷带接触镜。

要点

  • AmpB pεK凝胶在正常条件和马血清存在下18小时均对白色念珠菌有杀真菌活性。
  • 药物释放曲线高于治疗水平(0.188 μg/mL)达72小时,对HCE-T细胞系无细胞毒性。
  • 作者认为该凝胶有潜力作为体内抗真菌绷带接触镜,可能避免真菌性角膜炎的密集局部用药。

核心结论

  • AmpB pεK凝胶提供至少48小时的持续治疗性抗真菌活性且无角膜上皮细胞系细胞毒性,提示其有潜力作为体内抗真菌绷带接触镜。
  • 作者认为这可能避免真菌性角膜炎治疗中对密集局部用药的需求。

研究设计与样本

  • 体外研究:将两性霉素B(AmpB,0至30 μg/mL)与聚-ε-赖氨酸(pεK)水凝胶结合,评估对白色念珠菌的杀真菌效果、药物释放、药物稳定性及对HCE-T角膜上皮细胞系的细胞毒性。
  • 杀真菌效果在18和42小时通过光密度(OD600)和琼脂生长评估;泪液稀释效应通过将AmpB pεK凝胶在3.4 mL无菌PBS中储存24小时后再进行真菌孵育来模拟。
  • 药物释放通过HPLC评估96小时,药物稳定性通过OD600测试与凝胶结合状态下的药物至48小时。
  • 对HCE-T角膜上皮细胞系的细胞毒性在7天内评估。

主要发现

  • AmpB pεK凝胶在正常条件下18小时的OD600为0.057(SD 0.003,P < 0.005),在马血清存在下18小时的OD600为0.048(SD 0.028,P < 0.005),显示杀真菌活性。
  • 药物释放曲线高于治疗水平(0.188 μg/mL)达72小时。
  • 泪液稀释对较高浓度AmpB(3至10 μg/mL)无显著影响。
  • AmpB pεK凝胶对HCE-T细胞系无细胞毒性。

关键数值与推荐

  • AmpB浓度范围为0至30 μg/mL。
  • 杀真菌活性评估时间点为18和42小时。
  • 药物释放评估时长为96小时,药物稳定性测试至48小时。
  • 细胞毒性评估时长为7天。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to develop a more efficient drug delivery device to overcome the limitations of current drop therapy for the treatment of fungal keratitis. METHODS: Amphotericin B (AmpB), 0 to 30 μg/mL, was associated with a poly-ε-lysine (pεK) hydrogel. Fungicidal effect against Candida albicans was assessed at 18 and 42 hours by optical density (OD600) and growth on agar. Tear film dilution effect was mimicked by storage of AmpB pεK gels in 3.4 mL sterile PBS for 24 hours prior to fungal incubation. Drug elution over 96 hours was evaluated by HPLC, and drug stability was tested while associated with the gel by OD600 up to 48 hours. Lack of cytotoxicity toward the HCE-T corneal epithelial cell line was assessed over 7 days. RESULTS: AmpB pεK gels show fungicidal activity in normal conditions (0.057 OD600, SD 0.003, P < 0.005) and in the presence of horse serum (0.048 OD600, SD 0.028 P < 0.005) at 18 hours. The drug release profile was above therapeutic levels (0.188 μg/mL) for up to 72 hours. Tear dilution had no significant effect at higher concentrations of AmpB (3 to 10 μg/mL). AmpB pεK gels were not cytotoxic to the HCE-T cell line. CONCLUSIONS: We demonstrated that AmpB pεK gels confer sustained therapeutic antifungal activity for at least 48 hours without corneal epithelial cell line cytotoxicity, suggesting their potential for in vivo use as an antifungal bandage contact lens. This could avoid the need for intensive topical medication in the treatment of fungal keratitis.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Gallagher AG, McLean K, Stewart RMK, et al. Development of a Poly-ε-Lysine Contact Lens as a Drug Delivery Device for the Treatment of Fungal Keratitis. Invest Ophthalmol Vis Sci. 2017. PMID: 28873175. doi:10.1167/iovs.17-22301

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。